Anavex Life Sciences Corp (AVXL)

[McMagyar]

i disagree..

at somepoint the logic or what Anavex is presenting(Active 21 Hour metabolite) and past history of sigma 1 ligand action and muscarinic/cbd action will power Instittutional buying and some large investors who do not wish to miss the boat..


with company goal of "Access as quickly as possible" and the new policies of the FDA..big investors(retail and institutional) are not just gonnna wait..and ps(just in case you didn't know0 the Rett Syndrome Trial is already pre-screening patients and it's only a 12 week trial..which could have clinical results by the end of the year..

..